Allison M. Brady, Emmanuel B. Walter, Lauri E. Markowitz, Elizabeth R. Unger, & Gitika Panicker. (2020). Delayed dosing intervals for quadrivalent human papillomavirus vaccine do not reduce antibody avidity. Taylor & Francis Group.
Chicago Style (17th ed.) CitationAllison M. Brady, Emmanuel B. Walter, Lauri E. Markowitz, Elizabeth R. Unger, and Gitika Panicker. Delayed Dosing Intervals for Quadrivalent Human Papillomavirus Vaccine Do Not Reduce Antibody Avidity. Taylor & Francis Group, 2020.
MLA (9th ed.) CitationAllison M. Brady, et al. Delayed Dosing Intervals for Quadrivalent Human Papillomavirus Vaccine Do Not Reduce Antibody Avidity. Taylor & Francis Group, 2020.
Warning: These citations may not always be 100% accurate.